rolipram has been researched along with Amnionitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chorioamnionitis is implicated in the pathophysiology of bronchopulmonary disease, and the associated inflammatory response is responsible for adverse effects on alveolar development." | 1.38 | Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits. ( Branger, B; Caillon, J; Gras-Leguen, C; Homer, L; Jacqueline, C; Jarreau, PH; Joram, N; Launay, E; Méhats, C; Moyon, T; Potel, G; Roze, JC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homer, L | 1 |
| Launay, E | 1 |
| Joram, N | 1 |
| Jacqueline, C | 1 |
| Jarreau, PH | 1 |
| Caillon, J | 1 |
| Moyon, T | 1 |
| Branger, B | 1 |
| Potel, G | 1 |
| Roze, JC | 1 |
| Méhats, C | 1 |
| Gras-Leguen, C | 1 |
1 other study available for rolipram and Amnionitis
| Article | Year |
|---|---|
Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits.
Topics: Animals; Chorioamnionitis; Disease Models, Animal; Elastic Tissue; Female; Lung; Lung Volume Measure | 2012 |